Jonathan Gillis, CAO and Interim CFO at MapLight Therapeutics, Inc. (MPLT), sold 36,979 shares at $36.13 ($1.4M) on 2026-07-15, disclosed to the SEC on 2026-07-20.
Scheduled sale ($1.4M) by CAO and Interim CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.13 | 5,356 | $194K | 14.1% |
| 2 | $36.94 | 4,699 | $174K | 12.6% |
| 3 | $36.66 | 6,979 | $256K | 18.6% |
| 4 | $37.44 | 1,476 | $55K | 4.0% |
| 5 | $36.51 | 600 | $22K | 1.6% |
| 6 | $37.61 | 16,969 |
| $638K |
| 46.5% |
| 7 | $38.17 | 900 | $34K | 2.5% |
| Total | $37.12 avg | 36,979 | $1.4M | 100% |
| Filing → |